Sarah L Hulley1, Jeff Perring2, Nigel Manning3, Simon Olpin4, Sufin Yap5. 1. Sheffield Children's NHS Foundation Trust, Sheffield Children's Hospital, Western Bank, Sheffield, S10 2TH, UK. Sarah.hulley@nhs.net. 2. Sheffield Children's NHS Foundation Trust, Sheffield Children's Hospital, Western Bank, Sheffield, S10 2TH, UK. Jeff.perring@sch.nhs.uk. 3. Sheffield Children's NHS Foundation Trust, Sheffield Children's Hospital, Western Bank, Sheffield, S10 2TH, UK. Nigel.manning@sch.nhs.uk. 4. Sheffield Children's NHS Foundation Trust, Sheffield Children's Hospital, Western Bank, Sheffield, S10 2TH, UK. Simon.olpin@sch.nhs.uk. 5. Sheffield Children's NHS Foundation Trust, Sheffield Children's Hospital, Western Bank, Sheffield, S10 2TH, UK. Sufin.yap@sch.nhs.uk.
Abstract
Transient 5-oxoprolinuria is a phenomenon that is well recognised in adults. We illustrate an unusual paediatric case of transient 5-oxoprolinuria presenting during an episode of severe sepsis with concomitant paracetamol use. The 15-month-old patient had an extremely high anion gap metabolic acidosis. Adequate resuscitation failed to correct the biochemical disturbance, and high levels of 5-oxoproline were identified. A combination of haemofiltration, replenishment of glutathione stores with N-acetylcysteine and cessation of paracetamol administration resulted in the resolution of the acidosis. Subsequent testing following treatment of the sepsis revealed no ongoing 5-oxoprolinuria. CONCLUSION: Transient 5-oxoprolinuria has been previously reported in the adult population during episodes of severe sepsis and various pharmaceutical interventions. This case illustrates that it is a phenomenon that should be considered in paediatric patients where a very high anion gap metabolic acidosis exists that cannot be explained by the biochemical indices. WHAT IS KNOWN: • 5-oxoprolinuria in the paediatric population is usually secondary to an inborn error of metabolism. • Transient 5-oxoprolinuria is well recognised in adults during episodes of severe glutathione depletion. WHAT IS NEW: • Transient 5-oxoprolinuria is a phenomenon rarely reported in the paediatric population. • It highlights the importance of investigating a high anion gap such that unusual diagnoses are not missed.
Transient 5-oxoprolinuria is a phenomenon that is well recognised in adults. We illustrate an unusual paediatric case of transient 5-oxoprolinuria presenting during an episode of severe sepsis with concomitant paracetamol use. The 15-month-old patient had an extremely high anion gap metabolic acidosis. Adequate resuscitation failed to correct the biochemical disturbance, and high levels of 5-oxoproline were identified. A combination of haemofiltration, replenishment of glutathione stores with N-acetylcysteine and cessation of paracetamol administration resulted in the resolution of the acidosis. Subsequent testing following treatment of the sepsis revealed no ongoing 5-oxoprolinuria. CONCLUSION: Transient 5-oxoprolinuria has been previously reported in the adult population during episodes of severe sepsis and various pharmaceutical interventions. This case illustrates that it is a phenomenon that should be considered in paediatric patients where a very high anion gap metabolic acidosis exists that cannot be explained by the biochemical indices. WHAT IS KNOWN: • 5-oxoprolinuria in the paediatric population is usually secondary to an inborn error of metabolism. • Transient 5-oxoprolinuria is well recognised in adults during episodes of severe glutathione depletion. WHAT IS NEW: • Transient 5-oxoprolinuria is a phenomenon rarely reported in the paediatric population. • It highlights the importance of investigating a high anion gap such that unusual diagnoses are not missed.
Authors: John V Peter; Natasha Rogers; Shailesh Murty; Rosemarie Gerace; Richard Mackay; Sandra L Peake Journal: Med J Aust Date: 2006-08-21 Impact factor: 7.738
Authors: Andrew Z Fenves; Haskell M Kirkpatrick; Viralkumar V Patel; Lawrence Sweetman; Michael Emmett Journal: Clin J Am Soc Nephrol Date: 2006-04-19 Impact factor: 8.237
Authors: Yenifer Gamarra; Felipe C Santiago; Jorge Molina-López; José Castaño; Lourdes Herrera-Quintana; Álvaro Domínguez; Elena Planells Journal: Crit Care Date: 2019-05-07 Impact factor: 9.097